Ascendiant analyst Edward Woo raised the firm’s price target on Aemetis (AMTX) to $20 from $19 and keeps a Buy rating on the shares. The company reported weaker Q1 revenue but a positive outlook for 2025, the analyst tells investors in a research note. The firm says Aemetis’ large product potential for renewable fuels makes the stock attractive.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMTX: